Cargando…

Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models

The increased demand for physiologically relevant in vitro human skin models for testing pharmaceutical drugs has led to significant advancements in skin engineering. One of the most promising approaches is the use of in vitro microfluidic systems to generate advanced skin models, commonly known as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoio, Patrícia, Oliva, Abel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955316/
https://www.ncbi.nlm.nih.gov/pubmed/35336056
http://dx.doi.org/10.3390/pharmaceutics14030682
_version_ 1784676307194347520
author Zoio, Patrícia
Oliva, Abel
author_facet Zoio, Patrícia
Oliva, Abel
author_sort Zoio, Patrícia
collection PubMed
description The increased demand for physiologically relevant in vitro human skin models for testing pharmaceutical drugs has led to significant advancements in skin engineering. One of the most promising approaches is the use of in vitro microfluidic systems to generate advanced skin models, commonly known as skin-on-a-chip (SoC) devices. These devices allow the simulation of key mechanical, functional and structural features of the human skin, better mimicking the native microenvironment. Importantly, contrary to conventional cell culture techniques, SoC devices can perfuse the skin tissue, either by the inclusion of perfusable lumens or by the use of microfluidic channels acting as engineered vasculature. Moreover, integrating sensors on the SoC device allows real-time, non-destructive monitoring of skin function and the effect of topically and systemically applied drugs. In this Review, the major challenges and key prerequisites for the creation of physiologically relevant SoC devices for drug testing are considered. Technical (e.g., SoC fabrication and sensor integration) and biological (e.g., cell sourcing and scaffold materials) aspects are discussed. Recent advancements in SoC devices are here presented, and their main achievements and drawbacks are compared and discussed. Finally, this review highlights the current challenges that need to be overcome for the clinical translation of SoC devices.
format Online
Article
Text
id pubmed-8955316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89553162022-03-26 Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models Zoio, Patrícia Oliva, Abel Pharmaceutics Review The increased demand for physiologically relevant in vitro human skin models for testing pharmaceutical drugs has led to significant advancements in skin engineering. One of the most promising approaches is the use of in vitro microfluidic systems to generate advanced skin models, commonly known as skin-on-a-chip (SoC) devices. These devices allow the simulation of key mechanical, functional and structural features of the human skin, better mimicking the native microenvironment. Importantly, contrary to conventional cell culture techniques, SoC devices can perfuse the skin tissue, either by the inclusion of perfusable lumens or by the use of microfluidic channels acting as engineered vasculature. Moreover, integrating sensors on the SoC device allows real-time, non-destructive monitoring of skin function and the effect of topically and systemically applied drugs. In this Review, the major challenges and key prerequisites for the creation of physiologically relevant SoC devices for drug testing are considered. Technical (e.g., SoC fabrication and sensor integration) and biological (e.g., cell sourcing and scaffold materials) aspects are discussed. Recent advancements in SoC devices are here presented, and their main achievements and drawbacks are compared and discussed. Finally, this review highlights the current challenges that need to be overcome for the clinical translation of SoC devices. MDPI 2022-03-21 /pmc/articles/PMC8955316/ /pubmed/35336056 http://dx.doi.org/10.3390/pharmaceutics14030682 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zoio, Patrícia
Oliva, Abel
Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
title Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
title_full Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
title_fullStr Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
title_full_unstemmed Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
title_short Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
title_sort skin-on-a-chip technology: microengineering physiologically relevant in vitro skin models
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955316/
https://www.ncbi.nlm.nih.gov/pubmed/35336056
http://dx.doi.org/10.3390/pharmaceutics14030682
work_keys_str_mv AT zoiopatricia skinonachiptechnologymicroengineeringphysiologicallyrelevantinvitroskinmodels
AT olivaabel skinonachiptechnologymicroengineeringphysiologicallyrelevantinvitroskinmodels